glp-1 weight loss drug marketplace florida changes 2025 Trends: Costs & Coverage Barrier Amid Uncertainty Telehealth Weight Loss/GLP-1 Prescribing: What
Description
In recent years, the number of drug pipelines has steadily increased
[DOI] [PubMed] [Google Scholar] 65
Tirzepatide is currently the most potent weight-lowering drug approved
However, whether GLP-1RA induces pancreatitis or pancreatic cancer by affecting the expression level of related genes in the pancreas or by regulating the secretion of pancreatic enzymes is still inconclusive
All claims are sourced to primary literature
Retatrutide (LY3437943) is an investigational compound studied in clinical trials and is not FDA-approved for general use
